TY - JOUR
T1 - Body awareness training in the treatment of wearing-off related anxiety in patients with Parkinson's disease
T2 - Results from a pilot randomized controlled trial
AU - Ghielen, Ires
AU - van Wegen, Erwin E.H.
AU - Rutten, Sonja
AU - de Goede, Cees J.T.
AU - Houniet-de Gier, Marieke
AU - Collette, Emma H.
AU - Burgers-Bots, Ingrid A.L.
AU - Twisk, Jos W.R.
AU - Kwakkel, Gert
AU - Vermunt, Kees
AU - van Vliet, Bep
AU - Berendse, Henk W.
AU - van den Heuvel, Odile A.
PY - 2017/12/1
Y1 - 2017/12/1
N2 - Background In Parkinson's disease (PD) patients, fluctuations in symptoms commonly occur after many years of dopamine replacement therapy. The so-called wearing-off phenomenon exists of both motor and non-motor symptoms, such as rigidity and anxiety. Current treatment options are limited and an integrated approach is needed to address the complex interactions between motor and non-motor symptoms. Since wearing-off is eventually inevitable, treatment needs to focus on coping, acceptance and self-efficacy. We developed the body awareness training, named BEWARE, combining physical therapy with acceptance and commitment therapy to help PD patients deal better with wearing-off related anxiety (WRA). Methods This was an investigator-blinded randomized controlled trial. Forty PD patients with WRA were randomly assigned to the BEWARE or to the treatment as usual (TAU) condition. Assessments were performed prior to and immediately after the treatment period, and at 3-months follow up. The primary outcome was self-efficacy, secondary outcomes focused on mobility, daily functioning, anxiety, depression and quality of life. Results There was no significant improvement in self-efficacy in the BEWARE treatment condition when compared to TAU. However, standing balance and emotional wellbeing showed a significant improvement, and feelings of stigmatization showed a trend-significant decrease in the BEWARE condition. Conclusions We consider the BEWARE training to be a promising therapeutic approach to address WRA. Improvement points from the participants included 1) less frequent but longer therapy sessions; 2) active involvement of caregivers; and 3) the development of a supportive workbook. The optimized treatment protocol needs further evaluation in a phase III RCT. Trial registration: ClinicalTrials.gov identifier: NCT02054845
AB - Background In Parkinson's disease (PD) patients, fluctuations in symptoms commonly occur after many years of dopamine replacement therapy. The so-called wearing-off phenomenon exists of both motor and non-motor symptoms, such as rigidity and anxiety. Current treatment options are limited and an integrated approach is needed to address the complex interactions between motor and non-motor symptoms. Since wearing-off is eventually inevitable, treatment needs to focus on coping, acceptance and self-efficacy. We developed the body awareness training, named BEWARE, combining physical therapy with acceptance and commitment therapy to help PD patients deal better with wearing-off related anxiety (WRA). Methods This was an investigator-blinded randomized controlled trial. Forty PD patients with WRA were randomly assigned to the BEWARE or to the treatment as usual (TAU) condition. Assessments were performed prior to and immediately after the treatment period, and at 3-months follow up. The primary outcome was self-efficacy, secondary outcomes focused on mobility, daily functioning, anxiety, depression and quality of life. Results There was no significant improvement in self-efficacy in the BEWARE treatment condition when compared to TAU. However, standing balance and emotional wellbeing showed a significant improvement, and feelings of stigmatization showed a trend-significant decrease in the BEWARE condition. Conclusions We consider the BEWARE training to be a promising therapeutic approach to address WRA. Improvement points from the participants included 1) less frequent but longer therapy sessions; 2) active involvement of caregivers; and 3) the development of a supportive workbook. The optimized treatment protocol needs further evaluation in a phase III RCT. Trial registration: ClinicalTrials.gov identifier: NCT02054845
KW - Anxiety
KW - Body awareness
KW - Parkinson's disease
KW - Randomized controlled trial
KW - Self-efficacy
KW - Wearing-off
UR - http://www.scopus.com/inward/record.url?scp=85030473866&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85030473866&partnerID=8YFLogxK
U2 - 10.1016/j.jpsychores.2017.09.008
DO - 10.1016/j.jpsychores.2017.09.008
M3 - Article
AN - SCOPUS:85030473866
SN - 0022-3999
VL - 103
SP - 1
EP - 8
JO - Journal of Psychosomatic Research
JF - Journal of Psychosomatic Research
ER -